187
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Design, synthesis and bioactivities evaluation of novel oleanolic acid derivatives as potent PI3K inhibitors

, , &
Pages 264-276 | Received 22 Dec 2021, Accepted 12 Apr 2022, Published online: 21 Apr 2022
 

Abstract

Oleanolic acid has previously been shown to possess PI3K inhibitory activity, thus, the purpose of this work was to generate a series of derivatives that improve the potency. Twenty rationally designed oleanolic acid derivatives were synthesized and tested the cytotoxicity and PI3K inhibitory activity. The results suggested that attachment of additional structural elements such as association of thiazole group to A ring and insertion of phenylurea group was important for increasing activities. The most active derivative was compound II2, which exhibited PI3K inhibitory activity (IC50 = 58.42 nmol/l) and improved interaction with activity site of PI3K according with docking studies.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the National Natural Science Foundation of China (No. 21372156), the Science Foundation of Liaoning Province Department of Education (No. LJ2020025, No. LQ2020021, No. LJKZ0427), and key R & D project of Shenyang University of Chemical Technology (No. LDB2019001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.